Curtis Oltmans
2018 - Array BioPharma
In 2018, Curtis Oltmans earned a total compensation of $4M as General Counsel at Array BioPharma.
Compensation breakdown
| Bonus | $5,000 |
|---|---|
| Non-Equity Incentive Plan | $154,604 |
| Option Awards | $2,984,581 |
| Salary | $351,538 |
| Stock Awards | $305,760 |
| Other | $171,861 |
| Total | $3,973,344 |
Oltmans received $3M in option awards, accounting for 75% of the total pay in 2018.
Oltmans also received $5K in bonus, $154.6K in non-equity incentive plan, $351.5K in salary, $305.8K in stock awards and $171.9K in other compensation.
Rankings
In 2018, Curtis Oltmans' compensation ranked 2,807th out of 14,244 executives tracked by ExecPay. In other words, Oltmans earned more than 80.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,807 out of 14,244 | 80th |
Division Manufacturing | 1,038 out of 5,765 | 82nd |
Major group Chemicals And Allied Products | 356 out of 2,128 | 83rd |
Industry group Drugs | 293 out of 1,817 | 84th |
Industry Pharmaceutical Preparations | 225 out of 1,391 | 84th |
Source: SEC filing on September 14, 2018.
Oltmans' colleagues
We found four more compensation records of executives who worked with Curtis Oltmans at Array BioPharma in 2018.